May 23, 2025

HealthStream, Inc. (HSTM) Stock Analysis: Exploring a 24.01% Potential Upside for Investors

HealthStream, Inc. (NASDAQ: HSTM) is a notable player in the healthcare sector, specifically within the health information services industry. With a market capitalization of approximately $849.21 million, HealthStream offers a..

AxoGen, Inc. (AXGN) Stock Analysis: Exploring a 123% Potential Upside in the Medical Devices Sector

AxoGen, Inc. (NASDAQ: AXGN), a pivotal player in the healthcare sector, is garnering attention with its impressive potential upside of 123%. Specializing in the medical devices industry, AxoGen is renowned..

Arbutus Biopharma Corporation (ABUS) Stock Analysis: Potential 65% Upside in Biotech’s Fight Against Hepatitis B

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands at the forefront of innovative treatments in the biotechnology sector, focusing on developing novel therapeutics for infectious diseases, particularly chronic Hepatitis B. Investors intrigued..

Enhabit, Inc. (EHAB) Stock Analysis: Navigating Challenges in Healthcare with a Modest Upside

Enhabit, Inc. (EHAB), a key player in the U.S. healthcare sector, specializes in providing comprehensive home health and hospice services. With a market capitalization of $519.54 million, Enhabit operates within..

Castle Biosciences, Inc. (CSTL) Stock Analysis: Unveiling a Potential 125% Upside with Strong Buy Ratings

Castle Biosciences, Inc. (NASDAQ: CSTL), a pioneering force in the molecular diagnostics space, stands out for its promising potential in the healthcare sector. As of the latest trading data, the..

RxSight, Inc. (RXST) Stock Analysis: Unveiling a 33% Potential Upside Amidst Medical Device Innovation

RxSight, Inc. (NASDAQ: RXST) emerges as a compelling player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of approximately $645.72 million, this Aliso Viejo,..

Zymeworks Inc. (ZYME) Stock Analysis: Exploring an 87.77% Potential Upside in the Biotechnology Sector

Zymeworks Inc. (NASDAQ: ZYME), a clinical-stage biotechnology company, stands out in the healthcare sector with its innovative approach to biotherapeutics, particularly in oncology and autoimmune diseases. With a current market..

SI-BONE, Inc. (SIBN) Stock Analysis: Navigating a 33.91% Upside Potential in the Medical Device Space

For investors eyeing opportunities in the healthcare sector, SI-BONE, Inc. (NASDAQ: SIBN) presents a compelling case, particularly with a potential upside of 33.91% based on its average target price. Specializing..

Cogent Biosciences, Inc. (COGT): A Lucrative Investment with 226.91% Upside Potential

Cogent Biosciences, Inc. (NASDAQ: COGT) is a biotechnology company that has caught the attention of investors, particularly with its impressive potential upside of 226.91%. Specializing in developing precision therapies for..

ArriVent BioPharma, Inc. (AVBP) Stock Analysis: Exploring a Potential 91% Upside in the Biotech Sector

ArriVent BioPharma, Inc. (NASDAQ: AVBP) has garnered significant attention in the biotechnology sector, primarily due to its ambitious focus on cancer therapies and a remarkable potential upside of 91.47%. With..

Auna SA (AUNA) Stock Analysis: Potential Upside of 85.48% Sparks Investor Interest

Auna SA (AUNA), a prominent player in the healthcare sector, is capturing the attention of investors with its significant growth potential. Despite a challenging economic environment, the company stands out..

Talkspace, Inc. (TALK) Stock Analysis: Exploring a Promising 81% Upside Potential

Talkspace, Inc. (NASDAQ: TALK) is carving out a significant niche in the healthcare sector, specifically within health information services, by offering virtual behavioral healthcare. Headquartered in New York City, the..

Vir Biotechnology, Inc. (VIR): Investor Outlook with a Potential Upside of 287.74%

Vir Biotechnology, Inc. (NASDAQ: VIR) presents a unique opportunity within the biotechnology sector, particularly for investors who are keen on high-risk, high-reward profiles. With a current market capitalization of $637.28..

Amylyx Pharmaceuticals, Inc. (AMLX) Stock Analysis: Unveiling a 101.49% Potential Upside in the Biotech Sector

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) has emerged as an intriguing player in the biotechnology industry, capturing investor attention with its focus on developing breakthrough treatments for neurodegenerative diseases and endocrine..

Avadel Pharmaceuticals (AVDL) Stock Analysis: A Biopharma with Nearly 98% Upside Potential

Avadel Pharmaceuticals plc (NASDAQ: AVDL) is gaining attention in the healthcare sector, particularly among investors keen on the biopharmaceutical space. With a focus on developing innovative therapies, Avadel presents a..

Orthofix Medical Inc. (OFIX) Stock Analysis: Exploring a 117% Potential Upside

For investors eyeing opportunities in the healthcare sector, Orthofix Medical Inc. (NASDAQ: OFIX) presents a compelling case with a significant potential upside. Operating within the medical devices industry, Orthofix, headquartered..

Tectonic Therapeutic, Inc. (TECX) Stock Analysis: A Potential 273% Upside Awaits Investors

Tectonic Therapeutic, Inc. (NASDAQ: TECX), a burgeoning player in the biotechnology sector, is captivating investors’ attention with a compelling promise of significant upside potential. With a market capitalization of $414.53..

Cullinan Therapeutics, Inc. (CGEM) Investor Outlook: Exploring a Potential 249% Upside

Cullinan Therapeutics, Inc. (NASDAQ: CGEM), a biotechnology firm headquartered in Cambridge, Massachusetts, is capturing investor attention with a staggering potential upside of 249.45%. Specializing in developing innovative therapies for autoimmune..

Butterfly Network, Inc. (BFLY) Stock Analysis: Exploring a 94.70% Potential Upside in Medical Devices

Butterfly Network, Inc. (NASDAQ: BFLY) stands out in the healthcare sector with its innovative approach to medical imaging, offering handheld ultrasound devices that integrate directly with everyday technology. While the..

Immatics N.V. (IMTX) Stock Analysis: Uncovering a 192% Potential Upside in the Biotech Sector

Immatics N.V. (NASDAQ: IMTX) stands at an intriguing intersection of innovation and opportunity within the biotechnology sector. This German-based biopharmaceutical company is making significant strides in cancer treatment through its..

Search

Funds

May 23, 2025

Search

Funds

May 23, 2025

FTSE 100

Funds